findmyKOL
Clinical trialNCT07298408RecruitingPhase 1/PHASE2Interventional

Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study

SponsorFlorida A&M UniversityEnrollment20Diabetic NeuropathiesDiabetic Peripheral Neuropathic Pain (DPN)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • the Fsu Tmh Family Practice Residency Program

    Tallahassee, Florida, United States

    Narayan K Iyer, MDPhilip R Treadwell, PharmD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Apr 2026
Primary completion
31 Dec 2026
Completion
30 Jun 2027
Last update posted
29 Apr 2026
Registered enrollment
20
Registry id
NCT07298408

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.